Skip to main content
logo
Amerise Biosciences Limited (BOM:531681)
India flag India · Delayed Price · Currency is INR
1.010
+0.020 (2.02%)
At close: Jul 30, 2026

Amerise Biosciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
--1.880.360.0995.77
Revenue Growth
--423.68%307.95%-99.91%-
Gross Profit
--1.880.360.096.63
Operating Income
0.210.210.08-1.46-1.665.5
Net Income
0.160.160.06-1.46-1.195.49
Earnings Per Share
0.000.000.00-0.02-0.020.08
EPS Growth
204.64%204.64%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
5.925.920.220.210.140.13
Total Debt
----0.90.83
Net Cash (Debt)
5.925.920.220.21-0.76-0.7
Net Cash Growth
2566.22%2566.22%5.21%---
Net Cash Per Share
0.100.100.000.00-0.01-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-10.57-10.5730.71-1.69-1.320.61
Free Cash Flow
-10.57-10.5730.71-1.69-1.320.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
--100.00%100.00%100.00%6.92%
Operating Margin
--4.15%-405.85%-1884.09%5.74%
Pretax Margin
--4.04%-406.96%-1885.23%5.73%
Profit Margin
--3.03%-406.96%-1351.14%5.73%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
414.47242.121054.79--16.36
PS Ratio
--31.98121.46525.550.94